Interleukin-1 receptor antagonist treatment in acute ischaemic stroke does not alter systemic markers of anti-microbial defence (2019)
Attributed to:
Understanding and manipulating innate-like B cell mechanisms to prevent stroke-associated infection
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/587881
Publication URI: http://dx.doi.org/10.1101/587881
Type: Preprint